PPI
Research roundup
Debbie Rigby takes a look at the latest research news Evidence supporting the choice of a new cardiovascular risk equation for Australia The Australian CVD risk assessment and management guideline, …
Watch: OTC management of gastro-oesophageal reflux symptoms
Dr Brett MacFarlane provides an overview of reflux symptoms and management, including optimal use of medicines Reflux symptoms are common in the community and pharmacists are often the first acute …
Burning hearts
Pharmacy is often the first stop for patients with heartburn symptoms, but is the best diagnosis and advice being given? Heartburn (acid reflux) is a widespread complaint. According to The …
Spreading the word about GORD
Considering the key factors involved in proton pump Inhibitor therapy may assist pharmacists in initiating successful step-down attempts Gastro-oesophageal reflux disease (GORD) is a common complaint among the general community. …
Research Roundup
Debbie Rigby takes a look at the latest in research news Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke A UK population-based cohort study and linked …
The acid test
With restrictions now imposed on standard dose PPIs, have education initiatives had any impact on prescribing? Recently introduced restrictions on the prescribing of subsidised proton pump inhibitors have been supported …
Dosing on the agenda
Decision on PPI double dosing deferred by PBAC, but support given to antibiotic listing changes The Pharmaceutical Benefits Advisory Committee (PBAC) has deferred a decision on whether to allow twice …